Mott David M's Form 4 filing
Novavax Inc (NVAX) · filed Sep 24, 2021
- Accession no.
- 0001209191-21-057658
- Filed
- Sep 24, 2021
- Trade date
- Sep 23, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions. Open-market sales total $6.31M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mott David MCIK 0001219871 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 23, 2021 | Common Stock | SSaleDisposed | −5,728 | $251.32 | −$1,439,560.96 | 59,233 | Direct | |
| Sep 23, 2021 | Common Stock | SSaleDisposed | −7,557 | $252.56 | −$1,908,595.92 | 51,676 | Direct | |
| Sep 23, 2021 | Common Stock | SSaleDisposed | −7,744 | $253.46 | −$1,962,794.24 | 43,932 | Direct | |
| Sep 23, 2021 | Common Stock | SSaleDisposed | −2,732 | $254.46 | −$695,184.72 | 41,200 | Direct | |
| Sep 23, 2021 | Common Stock | SSaleDisposed | −1,200 | $255.38 | −$306,456 | 40,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.